Ritsuko Komaki MD FASTRO, FACR, FARS, FAAWR
Central Nervous System Cancer, Thoracic Cancer
Professor, Radiation Oncology, University of Texas Medical School at Houston
Join to View Full Profile
1515 Holcombe Blvd UT MDACCUnit 97Houston, TX 77030
Phone+1 713-563-2300
Dr. Komaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Ritsuko Komaki, MD is a radiation oncology specialist based in Houston, TX with subspecialities in central nervous system and thoracic cancers. Educated at Ascension Columbia St. Mary's Milwaukee Hospital and Medical College of Wisconsin Affiliated Hospitals, Dr. Komaki has been a Professor at MD Anderson Cancer Center since 1988 and has substantial experience in oncology and intensity-modulated radiation therapy. Her work has been published in respected journals, including JAMA Network Open and Cancer Research Communications, with several of her studies cited by other publications. She has also played a key role in numerous clinical trials focusing on various treatments for lung cancer. Dr. Komaki's outstanding work has been recognized with honors such as the Gold Medalist of ARS award in 2022 and the Gloria Lupton Tennison Endowed Chair for Lung Cancer Research at MDACC.
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Radiation Oncology, 1974 - 1978
Ascension Columbia St. Mary's Milwaukee HospitalInternship, Transitional Year, 1972 - 1973
OtherClass of 1969
Certifications & Licensure
TX State Medical License 1992 - 2026
WI State Medical License 1976 - 2017
NY State Medical License 1985 - 2007
American Board of Radiology Radiation Oncology- American Board of Radiology Therapeutic Radiology
Awards, Honors, & Recognition
- Gold Medalist of ARS in 2022
- Gloria Lupton Tennison Endowed Chair for the Lung Cancer Research at MDACC
Clinical Trials
- Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors Start of enrollment: 1993 Oct 01
- High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2007 Nov 01
- CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2003 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Comparison of predicted and actual dermatitis generated from computed tomography images and dose distribution maps.Yasuhide Miyabe, Saori Oshiro, Hiroto Seki, Yusuke Muroi, Eriko Kawashima
Technical Innovations & Patient Support in Radiation Oncology. 2024-12-01 - 1 citationsPrognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610-RTOG 0538.Michael K Farris, Michael D Mix, Xiaofei Wang, Brandy Jaszewski, Nathan Foster
JAMA Network Open. 2024-10-01 - 4 citationsLong-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial.Stephen G Chun, Chen Hu, Ritsuko U Komaki, Robert D Timmerman, Steven E Schild
JAMA Oncology. 2024-08-01
Grant Support
- RTOG, NRGNCI1988–2018
Committees
- Member, Institutional Board Review at MDACC 1998 - 2018
- Co-Chair, Lung Cancer Committee of RTOG/NRG 1998 - 2018
Research History
- PI of RTOGPI of RTOG from MDACC1990 - 2018
- Section Chief of Thoracic Radiation Oncology at MDACC1988 - 2018
Professional Memberships
- Member
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
